🏛️ Verified NIH Record • Updated 2025-07-30
REIMAGINE - Real World EvaluatIon of Mepolizumab in Severe Asthma achievinG on Treatment clinIcal remissioN, a prospEctive Study (NCT06041386)
A Prospective, Real-World, Interventional Study To Evaluate The Effect Of Mepolizumab On Achieving Clinical Remission In Participants With Severe Asthma
🔵 Active, Not Recruiting Phase4 💊 Investigational Drug / Biologic Sponsor: GlaxoSmithKline
🩺 Plain-English Summary (8th-Grade Level)
This is a prospective, real-world, single arm, global, multi-centre study to evaluate the effect of timely treatment with mepolizumab (NUCALA) to achieve clinical remission in adult participants with severe asthma with an eosinophilic phenotype (SA-EP).
Who can join: Review the eligibility criteria below.
Location: GSK Investigational Site — La Jolla, California
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (65 Sites)
Showing the first 25 of 65 sites.
- GSK Investigational Site — La Jolla, California
- GSK Investigational Site — Newport Beach, California
- GSK Investigational Site — Aurora, Colorado
- GSK Investigational Site — Colorado Springs, Colorado
- GSK Investigational Site — New Haven, Connecticut
- GSK Investigational Site — Homestead, Florida
- GSK Investigational Site — Jacksonville, Florida
- GSK Investigational Site — Miami, Florida
- GSK Investigational Site — Plantation, Florida
- GSK Investigational Site — Adairsville, Georgia
- GSK Investigational Site — Columbus, Georgia
- GSK Investigational Site — Lexington, Kentucky
- GSK Investigational Site — Owensboro, Kentucky
- GSK Investigational Site — New Orleans, Louisiana
- GSK Investigational Site — Glenn Dale, Maryland
- GSK Investigational Site — Towson, Maryland
- GSK Investigational Site — Ann Arbor, Michigan
- GSK Investigational Site — Rochester, Minnesota
- GSK Investigational Site — Henderson, Nevada
- GSK Investigational Site — Linwood, New Jersey
- GSK Investigational Site — Rochester, New York
- GSK Investigational Site — Schenectady, New York
- GSK Investigational Site — Philadelphia, Pennsylvania
- GSK Investigational Site — Philadelphia, Pennsylvania
- GSK Investigational Site — Union, South Carolina
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Asthma
- Investigating Dupilumab's Effect in Asthma by Genotype — Boston, Massachusetts
- Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting Beta-agonist (ICS/LABA) in Comparison to ICS Dose Escalation to High Dose ICS/LABA in Adolescent and Adult Patients With Uncontrolled Asthma — Bakersfield, California
- Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma — Saraland, Alabama
- Reduce IDentified UNcontrolled Asthma — San Diego, California
- A Dose Finding Study With an Anti-TSLP Antibody (GSK5784283) in Adults Aged 18 to 75 Years of Age With Uncontrolled Asthma — Little Rock, Arkansas
Explore by condition: All Asthma clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.